Brain tumour research in the spotlight at international conference

Dr. Nazar Vasyliv, CEO of The Global Alliance for Neurosurgical & Brain Cancer Research Innovations and a PhD candidate at the University of Edinburgh, will present groundbreaking research on combining photodynamic therapy with necroptosis in glioblastoma treatment at the 9th World Congress on Cancer Science & Therapy in London on March 2025. His presentation aims to enhance neurosurgical outcomes and improve treatment precision by targeting glioblastoma stem cells, ultimately reducing recurrence rates. Dr. Vasyliv's innovative approach has garnered recognition from the Scottish Government and validation from the Sahlgrenska Academy in Sweden, highlighting its potential to open new pathways in cancer treatment while preserving healthy tissue. Read more at Oncology News Today